Modulating the p66shc signaling pathway with protocatechuic acid protects the intestine from ischemia-reperfusion injury and alleviates secondary liver damage

ScientificWorldJournal. 2014 Mar 16:2014:387640. doi: 10.1155/2014/387640. eCollection 2014.

Abstract

Intestinal ischemia-reperfusion (I/R) injury is a serious clinical pathophysiological process that may result in acute local intestine and remote liver injury. Protocatechuic acid (PCA), which has been widely studied as a polyphenolic compound, induces expression of antioxidative genes that combat oxidative stress and cell apoptosis. In this study, we investigated the effect of PCA pretreatment for protecting intestinal I/R-induced local intestine and remote liver injury in mice. Intestinal I/R was established by superior mesenteric artery occlusion for 45 min followed by reperfusion for 90 min. After the reperfusion period, PCA pretreatment markedly alleviated intestine and liver injury induced by intestinal I/R as indicated by histological alterations, decreases in serological damage parameters and nuclear factor-kappa B and phospho-foxo3a protein expression levels, and increases in glutathione, glutathione peroxidase, manganese superoxide dismutase protein expression, and Bcl-xL protein expression in the intestine and liver. These parameters were accompanied by PCA-induced adaptor protein p66shc suppression. These results suggest that PCA has a significant protective effect in the intestine and liver following injury induced by intestinal I/R. The protective effect of PCA may be attributed to the suppression of p66shc and the regulation of p66shc-related antioxidative and antiapoptotic factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Hydroxybenzoates / pharmacology
  • Hydroxybenzoates / therapeutic use*
  • Intestinal Mucosa / metabolism*
  • Intestines / blood supply
  • Intestines / drug effects
  • Liver Diseases / drug therapy
  • Liver Diseases / metabolism*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Protective Agents / pharmacology
  • Protective Agents / therapeutic use
  • Random Allocation
  • Reperfusion Injury / metabolism*
  • Reperfusion Injury / prevention & control
  • Shc Signaling Adaptor Proteins / physiology*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Src Homology 2 Domain-Containing, Transforming Protein 1

Substances

  • Hydroxybenzoates
  • Protective Agents
  • Shc Signaling Adaptor Proteins
  • Shc1 protein, mouse
  • Src Homology 2 Domain-Containing, Transforming Protein 1
  • protocatechuic acid